Experimental compound reduces cell death, inflammation, and organ damage in diabetes

An experimental compound reduced the cell death, inflammation, and organ damage seen with diabetes.

Led by NYU Langone Health researchers, a new study in mice showed that a drug candidate prevented the interaction between two…